Epizyme (EPZM) Misses Q1 EPS by 71c

Epizyme (NASDAQ: EPZM) reported Q1 EPS of ($1.75), $0.71 worse than the analyst estimate of ($1.04). Revenue for the quarter came in at $911 thousand versus the consensus estimate of $5.63 thousand.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Ackman adds Netflix, Visa and Mastercard in portfolio revamp
• Azitra, Inc. (AZTR) Tops Q2 EPS by 54c